Members of the African Association of Nephrology (AFRAN) and the ISN Advocacy team collaborated for over a year to finalize the declaration designed to help advocate for better kidney health in Africa. Access the declaration here. "The Abidjan Declaration in Support of Kidney Care in the African Continent" was launched during the AFRAN's 2023 congress in...
Emerging Leaders Program member, Robert Kalyesubula Robert Kalyesubula (Uganda) joined the inaugural ISN Emerging Leaders Program (ELP) cohort in 2021. He recently featured in an article in The Guardian as the pioneer behind a successful local healthcare program in Uganda, the Balamu project, launched to tackle non-communicable diseases (NCDs) in the region. Read the newspaper article...
Dr. Nick Medjeral-Thomas (UK) hosts this edition of the ISN Global Kidney Care Podcast. He joins fellow nephrologists Dr. Namrata Parikh (Canada) and Dr. Gary Chan (Hong Kong) to discuss the diagnosis and management of complement-mediated kidney diseases. All three are involved in developing the ISN Complement-mediated Kidney Disease Toolkit, launched in 2022. Listen to...
The ISN submitted three statements supporting global kidney health when it participated in the 152nd session of the World Health Organization’s Executive Board from January 30 to February 7, 2023. This annual meeting gathers WHO executive board members at the start of each year to agree on World Health Assembly agenda resolutions for consideration by...
Read the application guidelines and eligibility criteria here or apply directly here if you are an ISN member. The ISN Clinical Research Program supports research and education initiatives that help detect and manage non-communicable chronic diseases such as CKD, AKI, hypertension, diabetes, and cardiovascular disease in low-income, lower-middle-income, and upper-middle-income countries. The deadline to apply is May 1, but proposals...
The first ISN Emerging Leaders Program (ELP) cohort developed a web-based multinational survey of healthcare workers to assess access and explore barriers to essential medicines in low and low to middle-income countries for people with CKD. Read the article on the results of the survey here. The survey confirms data from the 2019 ISN Global Kidney...
The consensus report identifies and highlights shared recommendations from the 2022 American Diabetes Association (ADA) Standards of Medical Care in Diabetes and the Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Read the consensus report here. Consensus statements were drafted when recommendations from each organization aligned and...
ISN Mentee Emmy Bell with ISN President and Mentor, Agnes Fogo The ISN Mentorship Program supports mutual learning partnerships within the ISN global community. Mentees work toward specific professional goals, while mentors develop coaching and leadership skills. Since December 2021, ISN mentee Dr. Emmy Bell, a nephrology specialist at the University of Alabama at Birmingham (UAB),...
The ISN has officially submitted its list of comments on the recently published 2nd draft of the updated Appendix 3 to the “Global Action Plan for the prevention and control of noncommunicable diseases (NCDs) 2013–2030” to the World Health Organization (WHO). Designed to support the implementation of the action plan's six objectives, Appendix 3 outlines...
Today marks the start of the Global Week for Action on Non-communicable Diseases (NCDs), with activities taking place worldwide to raise awareness of the urgent need for increased financing to prevent and treat NCDs and build resilient health systems. With an estimated 41 million deaths yearly, NCDs constitute the leading cause of death and disability...
